Aprea Therapeutics, Inc. (APRE)
Operating Cash Flow (Statement)
-$12.17M
TTM · Period ending: · USD
APRE Operating Cash Flow (Statement)
Latest reported-$12.17Mperiod ending
Latest reported-$12.17Mperiod ending
APRE TTM Cash from Operations (-$26.64M → -$12.17M)
TTM operating cash flow (statement)
High-resolution chart · PNG
APRE operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -12,168,011 | |
| -12,020,002 | |
| -12,894,439 | |
| -13,444,051 | |
| -12,741,123 | |
| -13,251,990 | |
| -13,556,718 | |
| -13,785,472 | |
| -13,559,135 | |
| -13,134,418 | |
| -12,177,608 | |
| -12,458,462 | |
| -16,809,179 | |
| -22,494,888 | |
| -25,011,136 | |
| -31,169,411 | |
| -32,810,133 | |
| -31,659,403 | |
| -37,686,180 | |
| -40,706,595 | |
| -45,631,316 | |
| -47,517,746 | |
| -43,537,265 | |
| -40,767,508 | |
| -34,022,349 | |
| -29,984,133 | |
| -26,639,854 | |
| -20,061,678 | |
| -16,800,843 |